Mirum Pharmaceuticals, Inc. MIRM Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s financing cash flow?
- Mirum Pharmaceuticals, Inc. (MIRM) reported financing cash flow of $270.08M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s financing cash flow increased by 4147.2% year-over-year, from $6.36M to $270.08M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s financing cash flow has grown at a -14.0% compound annual growth rate (CAGR), from $73.47M to $40.14M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.